• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 453
  • 253
  • 81
  • 58
  • 28
  • 20
  • 13
  • 9
  • 9
  • 8
  • 8
  • 6
  • 6
  • 5
  • 5
  • Tagged with
  • 1057
  • 234
  • 206
  • 124
  • 117
  • 115
  • 95
  • 86
  • 83
  • 83
  • 73
  • 70
  • 65
  • 60
  • 57
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
391

The Usability Testing of the Web Accessible Population Pharmacokinetics Service- Hemophilia

Barghash, Islam 11 1900 (has links)
Hemophilia is a genetic disorder that is caused by deficiencies in coagulation factor VIII and factor IX. Optimal management of hemophilia requires tailoring the dose of treatment to the individual patient’s need. This tailoring is based on several clinical considerations, for example, bleeding phenotype and desired level of activity, and estimated individual pharmacokinetic (PK) parameters. While a classical PK approach would require several post infusion blood samples taken over multiple days, a population PK approach might enable individual assessment using fewer samples. Health information technologies can support implementation of sophisticated, easily available, point-of care resources to estimate PK values with a population approach. The Web Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) is a proposal for such a solution, developed at McMaster University. Once tested, it will be offered to hemophilia centres worldwide. The objective of the study was to investigate the ease of use (usability) of the WAPPS-Hemo web interface among clinicians and other people who treat hemophilia through two iterative cycles of usability testing. The total number of participants was 13, and they were physicians, nurses and research coordinators. The think aloud technique was selected for testing to gain feedback and comments on the participants’ thought processes while interacting with the system and discover interface design problems. Additionally, the System Usability Scale (SUS) questionnaire was used to obtain data on user satisfaction. The initial assessment of the prototypal WAPPS-Hemo interface with SUS reported a score of 70.5, which is considered an above average score. We received many useful suggestions through two iterations of user testing, ending with a final SUS score of 73 after implementation of the suggested improvements. Verbal feedback from users in the second round showed that users experienced an easier and more intuitive interaction with the system. Usability testing and analyses were conducted in this study to discover user interface issues and to determine the usability and learnability of the WAPPS-Hemo service among various potential users. Through iterative cycles, application of the think aloud technique, and the SUS questionnaire, we optimized the usability of the WAPPS- Hemo program and have moved to implementation (June 2015). / Thesis / Master of Science (MSc)
392

EFFECTS OF ANTIOXIDANT STATUS AND ORAL DELIVERY SYSTEMSON QUERCETIN BIOAVAILABILITY

Guo, Yi 28 August 2014 (has links)
No description available.
393

Pharmacokinetic Evaluation and Modeling of Tyrosine Kinase Inhibitors Nilotinib and Imatinib in Preclinical Species to Aid their Repurposing As Anti-Viral Agents

Ananthula, Hari Krishna 05 December 2017 (has links)
No description available.
394

Pharmacogenetic Impact on Metabolism and Cytochrome P450 (CYP)3A Inductive Effect of Tamoxifen

Mugundu, Ganesh January 2009 (has links)
No description available.
395

Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin

Samineni, Divya 23 September 2011 (has links)
No description available.
396

Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-clinical Mechanistic Assessment

Moorthy, Ganesh 11 September 2015 (has links)
No description available.
397

Pharmacokinetics and Pharmacodynamics of Fentanyl in Alpacas after Intravenous and Transdermal Administration

Lovasz, Michael F. 27 September 2016 (has links)
No description available.
398

The pharmacology, pharmacokinetics and metabolism of a novel nonsteroidal selective androgen receptor modulator

Perera, Minoli A. January 2003 (has links)
No description available.
399

Optimization of cancer chemotherapy: local delivery of paclitaxel and pharmacokinetics of suramin

Hu, Xiao January 2004 (has links)
No description available.
400

Pharmacokinetics, pharmacodynamics and metabolism of GTI-2040, a phosphorothioate oligonucleotide targeting R2 subunit of ribonucleotide reductase

Wei, Xiaohui 14 July 2006 (has links)
No description available.

Page generated in 0.0466 seconds